American Capital Advisory’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
American Capital Advisory's RGEN Position: Q2 2026 in Review
American Capital Advisory increased its Repligen (RGEN) stake by 200% in Q2 2026, buying an estimated $737 and bringing the position to 9 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #745.
American Capital Advisory first reported a position in RGEN in Q2 2025 and has held it in 3 quarters since. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- American Capital Advisory held 9 shares of Repligen worth $1.23K as of Q2 2026.
- American Capital Advisory bought 6 Repligen shares in Q2 2026, an estimated $737.
- Repligen made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #745 holding.
- American Capital Advisory first reported a position in Repligen in Q2 2025 and has held it in 3 quarters since.
- 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.